ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
ITGA4 is a potential biomarker and therapeutic target to enhance cancer treatment and improve patient outcomes.
Authors
- Futian Tang (ORCID: https://orcid.org/0000-0001-9495-7695)
- Song Wang (ORCID: https://orcid.org/0000-0003-1129-8044)
- Gang Wang (ORCID: https://orcid.org/0000-0001-6500-5863)
- Jie Liu (ORCID: https://orcid.org/0000-0002-1257-5317)
- Jiaxing Zhang (ORCID: https://orcid.org/0000-0002-0178-7007)
- Yumin Li (ORCID: https://orcid.org/0000-0002-9267-1412)
Institutions
- Queensland University of Technology (AU)
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-12
- DOI
- https://doi.org/10.3389/fonc.2025.1513622
- Citations
- 7
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 7.32